Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

X Y Chu

Showing results (1-10 of 17) with videos related to

Pageof 2
Sort By:
Zhonghua Nei Ke Za Zhi|June 1, 1984
[Familial osteomalacia]X Y Chu
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|June 23, 2018
[Effects of RhoA on the adherens junction of murine ameloblasts]L Yang, X Y Chu, Q Zhao
Cancer Research|May 15, 1997
Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in ratsX Y Chu, Y Kato, Y Sugiyama
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 2, 1999
Possible involvement of P-glycoprotein in biliary excretion of CPT-11 in ratsX Y Chu, Y Kato, Y Sugiyama
Genetics and Molecular Research : GMR|April 14, 2015
Clinical significance of lymphatic vessel invasion in stage I non-small cell lung cancer patientsK F Ma, X Y Chu, Y Liu
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 1, 1994
[Pharmacokinetics and disposition of vinpocetine in rats]J H Yao, C Y Su, X Y Chu
The Journal of Pharmacology and Experimental Therapeutics|January 26, 1999
Active efflux of CPT-11 and its metabolites in human KB-derived cell linesX Y Chu, H Suzuki, K Ueda, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2)T Hirohashi, H Suzuki, X Y Chu, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in ratsX Y Chu, Y Kato, K Niinuma, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|August 14, 2024
[Prediction of the clinical supply of blood components in Xi'an City from 2023 to 2025]L H Zhang, J Wang, B Yao, et al.
Pageof 2

Showing results (1-10 of 17) with videos related to

Sort By:
Pageof 2
Zhonghua Nei Ke Za Zhi|June 1, 1984
[Familial osteomalacia]X Y Chu
Beijing Da Xue Xue Bao. Yi Xue Ban = Journal of Peking University. Health Sciences|June 23, 2018
[Effects of RhoA on the adherens junction of murine ameloblasts]L Yang, X Y Chu, Q Zhao
Cancer Research|May 15, 1997
Multiplicity of biliary excretion mechanisms for irinotecan, CPT-11, and its metabolites in ratsX Y Chu, Y Kato, Y Sugiyama
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 2, 1999
Possible involvement of P-glycoprotein in biliary excretion of CPT-11 in ratsX Y Chu, Y Kato, Y Sugiyama
Genetics and Molecular Research : GMR|April 14, 2015
Clinical significance of lymphatic vessel invasion in stage I non-small cell lung cancer patientsK F Ma, X Y Chu, Y Liu
Yao Xue Xue Bao = Acta Pharmaceutica Sinica|January 1, 1994
[Pharmacokinetics and disposition of vinpocetine in rats]J H Yao, C Y Su, X Y Chu
The Journal of Pharmacology and Experimental Therapeutics|January 26, 1999
Active efflux of CPT-11 and its metabolites in human KB-derived cell linesX Y Chu, H Suzuki, K Ueda, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 22, 1999
Function and expression of multidrug resistance-associated protein family in human colon adenocarcinoma cells (Caco-2)T Hirohashi, H Suzuki, X Y Chu, et al.
The Journal of Pharmacology and Experimental Therapeutics|April 1, 1997
Multispecific organic anion transporter is responsible for the biliary excretion of the camptothecin derivative irinotecan and its metabolites in ratsX Y Chu, Y Kato, K Niinuma, et al.
Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]|August 14, 2024
[Prediction of the clinical supply of blood components in Xi'an City from 2023 to 2025]L H Zhang, J Wang, B Yao, et al.
Pageof 2